{"id":16905,"date":"2025-08-25T16:35:02","date_gmt":"2025-08-25T16:35:02","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/blog\/chemistrys-role-in-preclinical-drug-discovery\/"},"modified":"2025-08-25T16:35:02","modified_gmt":"2025-08-25T16:35:02","slug":"chemistrys-role-in-preclinical-drug-discovery","status":"publish","type":"blog","link":"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/chemistrys-role-in-preclinical-drug-discovery\/","title":{"rendered":"From Molecule to Kilo: Rethinking Chemistry\u2019s Role in Preclinical Drug Discovery"},"content":{"rendered":"\n

In preclinical drug discovery, chemistry is often seen as a series of transactions: design a compound, synthesize it, purify it, test it. But when timelines tighten and complexity increases, as they inevitably do, that modular view begins to break down. Instead, companies are realizing that chemistry isn\u2019t just a service, it\u2019s a strategic enabler. And when integrated early and intelligently, it can transform the pace and predictability of a program. But that integration is easier said than done<\/strong>.<\/h2>\n\n\n\n

The Hidden Costs of Fragmented Chemistry<\/h3>\n\n\n\n

For biotech and pharma teams under pressure to move fast, the biggest risks often aren\u2019t in the science, they\u2019re in the handoffs. Working across multiple vendors or loosely connected internal teams can lead to:<\/p>\n\n\n\n

    \n
  • Gaps in knowledge<\/strong>\u00a0that delay decision-making<\/li>\n\n\n\n
  • Misaligned priorities<\/strong>\u00a0between chemistry and biology<\/li>\n\n\n\n
  • Purification bottlenecks<\/strong>\u00a0that stall delivery<\/li>\n\n\n\n
  • Lack of scalability<\/strong>, especially when a lead compound must suddenly move to preclinical supply<\/li>\n<\/ul>\n\n\n\n

    These frictions don\u2019t just slow things down, they increase cost, risk, and the likelihood of having to rework what\u2019s already been done.<\/p>\n\n\n\n

    What Integrated Chemistry Should Look Like<\/h3>\n\n\n\n

    In an ideal world, a discovery program would flow seamlessly from early SAR exploration to preclinical candidate nomination, with chemistry at its core, connected to biology, DMPK, protein sciences, and informatics in real time.<\/p>\n\n\n\n

    A modern chemistry strategy should include:<\/p>\n\n\n\n

      \n
    • Medicinal chemistry<\/strong>\u00a0that\u2019s tightly linked to emerging data<\/li>\n\n\n\n
    • Process chemistry and analytical support<\/strong>\u00a0ready to scale when needed<\/li>\n\n\n\n
    • Purification tools<\/strong>\u00a0that can adapt to the compound, not the other way around<\/li>\n\n\n\n
    • High-throughput tools<\/strong>\u00a0like parallel synthesis and DoE to explore more, faster<\/li>\n\n\n\n
    • Built-in flexibility<\/strong>\u00a0to pivot between small-scale discovery and kilo-scale delivery without delay<\/li>\n<\/ul>\n\n\n\n

      That\u2019s not just operational efficiency, it\u2019s a competitive advantage.<\/p>\n\n\n\n

      The Journey to Kilo: When Scale Starts to Matter<\/h3>\n\n\n\n

      One of the key inflection points in any drug discovery project is the transition from exploratory chemistry to scale-up. It\u2019s often where momentum is lost, not because of scientific failure, but because of lack of preparedness<\/strong>.<\/p>\n\n\n\n

      Phase-appropriate process development, smart purification strategies, and continuity between discovery and preclinical supply are essential to cross that gap smoothly. That doesn\u2019t mean jumping to GMP before it\u2019s necessary, but it does mean thinking ahead.<\/p>\n\n\n\n

      Purification: Often Overlooked, Often the Bottleneck<\/h3>\n\n\n\n

      Few things frustrate a program more than knowing what needs to be made, but not being able to isolate it at the right purity, at the right scale, or in the right timeframe<\/strong>.<\/p>\n\n\n\n

      The ability to pivot between analytical HPLC<\/strong>, prep HPLC<\/strong>, and preparative SFC<\/strong>, with no equipment limitations, can make or break a program\u2019s momentum. Especially when:<\/p>\n\n\n\n

        \n
      • Chiral resolution is required<\/li>\n\n\n\n
      • Multiple isomers must be separated in a single step<\/li>\n\n\n\n
      • A compound fails elsewhere due to poor peak shape or scale-up limitations<\/li>\n<\/ul>\n\n\n\n

        A separation sciences strategy built for speed, flexibility, and precision<\/strong> can turn weeks of troubleshooting into a day\u2019s work.<\/p>\n\n\n\n

        Reframing Chemistry as a Competitive Lever<\/h3>\n\n\n\n

        More and more teams are recognizing that the value of chemistry isn\u2019t just in the molecules, it\u2019s in the choices it enables<\/strong>. When purification, process development, analytical chemistry, and design are aligned, drug discovery becomes more than a sprint, it becomes scalable.<\/p>\n\n\n\n

        Programs that succeed in today\u2019s market are built on:<\/p>\n\n\n\n

          \n
        • Early-stage chemistry aligned with late-stage thinking<\/strong><\/li>\n\n\n\n
        • High-quality data packages that are CDMO-transfer ready<\/strong><\/li>\n\n\n\n
        • Fast-turnaround answers from deeply embedded scientific teams<\/strong><\/li>\n<\/ul>\n\n\n\n

          This isn\u2019t about adding layers of complexity. It\u2019s about reducing friction, and letting innovation move at the pace it was meant to.<\/p>\n\n\n\n

          Why This Matters<\/h3>\n\n\n\n

          You\u2019ve probably worked with a CRO, or multiple, where bottlenecks started to appear once complexity increased: a novel structure with tricky solubility, a late-stage scale-up need, a molecule that failed purification at a critical moment.<\/p>\n\n\n\n

          That\u2019s where integrated chemistry, separation sciences, and scalability aren\u2019t just differentiators, they\u2019re project-savers.<\/p>\n\n\n\n

          Closing Thought: Building with the End in Mind<\/h3>\n\n\n\n

          In drug discovery, we\u2019re all trying to do the same thing:\u00a0turn ideas into therapies, faster and more predictably<\/strong>. That requires chemistry that\u2019s not just good, it\u2019s\u00a0built for your biology, your timelines, and your goals<\/strong>.<\/h2>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","category":[797,819],"class_list":["post-16905","blog","type-blog","status-publish","hentry","category-chemistry","category-decouverte-integree-de-medicaments"],"acf":[],"yoast_head":"\nFrom Molecule to Kilo: Rethinking Chemistry\u2019s Role in Preclinical Drug Discovery - Sygnature<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/chemistrys-role-in-preclinical-drug-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"From Molecule to Kilo: Rethinking Chemistry\u2019s Role in Preclinical Drug Discovery - Sygnature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/chemistrys-role-in-preclinical-drug-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/sygnature-hit-to-lead-team-collaboration-scaled.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/blog\\\/chemistrys-role-in-preclinical-drug-discovery\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/blog\\\/chemistrys-role-in-preclinical-drug-discovery\\\/\",\"name\":\"From Molecule to Kilo: Rethinking Chemistry\u2019s Role in Preclinical Drug Discovery - Sygnature\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"datePublished\":\"2025-08-25T16:35:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/blog\\\/chemistrys-role-in-preclinical-drug-discovery\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/blog\\\/chemistrys-role-in-preclinical-drug-discovery\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/blog\\\/chemistrys-role-in-preclinical-drug-discovery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"From Molecule to Kilo: Rethinking Chemistry\u2019s Role in Preclinical Drug Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"From Molecule to Kilo: Rethinking Chemistry\u2019s Role in Preclinical Drug Discovery - Sygnature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/chemistrys-role-in-preclinical-drug-discovery\/","og_locale":"fr_CA","og_type":"article","og_title":"From Molecule to Kilo: Rethinking Chemistry\u2019s Role in Preclinical Drug Discovery - Sygnature","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/chemistrys-role-in-preclinical-drug-discovery\/","og_site_name":"Sygnature","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/sygnature-hit-to-lead-team-collaboration-scaled.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/chemistrys-role-in-preclinical-drug-discovery\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/chemistrys-role-in-preclinical-drug-discovery\/","name":"From Molecule to Kilo: Rethinking Chemistry\u2019s Role in Preclinical Drug Discovery - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"datePublished":"2025-08-25T16:35:02+00:00","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/chemistrys-role-in-preclinical-drug-discovery\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/blog\/chemistrys-role-in-preclinical-drug-discovery\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/chemistrys-role-in-preclinical-drug-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"From Molecule to Kilo: Rethinking Chemistry\u2019s Role in Preclinical Drug Discovery"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/blog\/16905","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/blog"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/blog"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/blog\/16905\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=16905"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=16905"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}